The SITC Forward Fund is pleased to announce the recipients of 2023 SITC Fellowships to support the next generation of cancer immunotherapy and tumor immunology experts through dedicated funding of impactful research.
The 2023 SITC Fellowships recipients are:
SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship
Award Amount: $200,000 (two-year)
Recipient: Tyler E. Miller, MD, PhD
Institution: Massachusetts General Hospital
Project Title: "Identifying interventions that target the immunosuppressive microenvironment in solid tumors"
SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship
Award Amount: $100,000 (one-year)
Recipient: Pamela Basto, MD, PhD
Institution: Stanford University
Project Title: "Development of Cellular Therapies Targeting Aberrant Glycosylation in Lung Adenocarcinoma"
SITC-Merck Cancer Immunotherapy Clinical Fellowship
Award Amount: $100,000 (one-year)
Awardee: Eisuke Tomiyama, MD, PhD
Institution: University of British Columbia
Project Title: "Elucidation of the role of EphA2 in the immune evasion of bladder cancer to overcome resistance to immune-checkpoint inhibitors"
SITC-Genentech Women in Cancer Immunotherapy Fellowship
Award Amount: $100,000 (one-year)
Recipient: Kylynda C. Bauer, PhD
Institution: National Cancer Institute
Project Title: "Vagal-CD8+ T cell axis: Harnessing neuroimmune circuits to alter anti-tumor immunity in liver cancer"
SITC Diversity, Equity and Inclusion Fellowship
Award Amount:$100,000 (one-year)
Recipient: Shaquia L. Idlett-Ali, PhD
Institution: University of Colorado
Project Title: "Targeting nerve-mediated immunosuppression in the tumor microenvironment for head and neck squamous cell carcinoma"
SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship
Award Amount: $40,000 (one-year)
Recipient: Guido Ghilardi, MD
Institution: University of Pennsylvania
Project Title: "The role of lymphodepletion in CAR T cell-associated toxicities"
2024 NCI Immunotherapy Fellowship
Award: This one-year program allows the fellow to have exposure to multiple clinical immunotherapeutic approaches and also to key opinion leaders in the field of clinical immunotherapy.
Co-Sponsored by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and SITC, made possible in part by an educational grant from EMD Serono.
Awardee: Julie Ma, MD
Institution: University of California, Los Angeles